Chemical Maker Settles Price- Fixing Lawsuit for $10M

Specialty chemicals maker Cabot Corp. has agreed to settle the federal class action lawsuits pending against the company that alleged it and other carbon black manufacturers violated antitrust laws.

There may be Millions of Faulty Chinese Tires on the Market

It now appears there may be millions of faulty Chinese tires on the highways in this country. The suspect tires have been sold in the United States and apparently are far more in number than initial estimates indicated.

The FDA Continues to Fail to do its Job

There can be little doubt that over the years the federal Food and Drug Administration has been controlled to a great extent by the politically powerful pharmaceutical industry.

Insurer to pay $20M in Bad Faith Insurance Case

In the largest settlement to date in a Pennsylvania insurance bad faith case, The Princeton Insurance Co. has agreed to pay $20 million to settle a claim brought on behalf of a tavern that was hit with a $75 million verdict in a Dram Shop Act lawsuit.

Doctors Hesitate to Prescribe Ortho Evra

A group of doctors in Tennessee has decided to stop prescribing the Ortho Evra patch to patients over concerns that the device could increase their risk of blood clots or other problems

Avandia, Other Diabetes Drugs to Add Boxed Warning

GlaxoSmithKline (GSK) has agreed to add a boxed warning about the risk of heart failure to the label of its Type 2 diabetes drug Avandia.

15 Confirmed Cases of Asbestos Exposure in West Texas

So far, 15 West Dallas workers and residents show signs of asbestos-related illnesses such as mesothelioma, asbestosis and cancer.

A Most Significant Vioxx Ruling

U.S. Food and Drug Administration approval of a drug label doesn't release the manufacturer of claims that its warnings are inadequate.

Jury gets Case in McFadden-Weaver Mortgage Fraud Trial

A federal jury will continue its mortgage fraud deliberations today, after Saundra McFadden-Weaver testified Wednesday that she never knowingly misrepresented information on loan documents she signed in 2005.

Timing of FDA Notice on Diabetes Meds Leads to Confusion

FDA notice of black-box warnings for GlaxoSmithKline's Avandia, and drugs like it, for congestive heart failure came as a surprise to many.